Suchen
Simulations Plus Inc
SLPZur Watchlist hinzufügen
18.230USD
-0.070-0.38%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
368.70MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Simulations Plus Inc Unternehmen
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Simulations Plus Inc Informationen
BörsenkürzelSLP
Name des UnternehmensSimulations Plus Inc
IPO-datumJun 18, 1997
CEOO'Connor (Shawn M)
Anzahl der mitarbeiter212
WertpapierartOrdinary Share
GeschäftsjahresendeJun 18
Addresse800 Park Offices Drive, Suite 401
StadtRESEARCH TRIANGLE PARK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl27709
Telefon16617237723
Websitehttps://www.simulations-plus.com/
BörsenkürzelSLP
IPO-datumJun 18, 1997
CEOO'Connor (Shawn M)
Führungskräfte von Simulations Plus Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.13%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Lisa Lavange
Dr. Lisa Lavange
Independent Director
Independent Director
--
--
Mr. William (Will) Frederick
Mr. William (Will) Frederick
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Jonathan Chauvin
Dr. Jonathan Chauvin
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.13%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Simulations Plus Inc?
Die fünf größten Anteilseigner von Simulations Plus Inc sind: Dr. Hon. Walter S. Woltosz
Wie viele Institutionen halten Anteile an Simulations Plus Inc (SLP)?
Mit Stand vom 2026Q1 halten 432 Institutionen Anteile an Simulations Plus Inc, mit einem Gesamtmarktwert von etwa 17.68M, was 87.48% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4627215.00 gestiegen.
Was ist die größte Einnahmequelle von Simulations Plus Inc?
Am 2026Q1 erzielte das Geschäft mit Consulting services für Simulations Plus Inc den höchsten Umsatz in Höhe von 9.54M, was 51.78% des Gesamtumsatzes entspricht.